FMCG giant Johnson & Johnson has announced a three year extension to the Johnson & Johnson Innovation Partnering Office at Queensland University of Technology (JJIPO @ QUT).
The extension of the joint initiative will allow for continued life-science innovative research, new product development as well as local job creation in Queensland.
The JJIPO @ QUT was launched in 2016 to provide support to researchers and companies in the state’s life-science sector as part of a $650 million Advance Queensland initiative.
Speaking at the AusBiotech National Conference in Brisbane on Thursday Head of Johnson & Johnson Innovation, California, Dr. Rowan Chapman, said the collaboration aims to bring Queensland’s healthcare solutions to the world stage.
“Australia has a pioneering healthcare ecosystem, and this initiative represents Johnson & Johnson Innovation’s ongoing commitment to both helping connect life-science innovators in Queensland to the global innovation ecosystem and bringing Queensland’s home-grown healthcare solutions to the wider world,” Chapman said.
In its first two years, JJIPO @ QUT has helped accelerate innovation in Queensland with notable collaborations including potential new treatments for rheumatoid arthritis and other autoimmune diseases, as well as a saliva-based diagnostic for the early detection of throat cancers.
Since its inception, the two have collaborated on 40 educational training and networking events and over 20 international executive visits from the J&J Family of Companies to provide mentorship to entrepreneurs, investors, academics, government and industry stakeholders
JJIPO @ QUT works with healthcare companies and researchers across Queensland, providing commercialisation training, mentoring and networking support free of charge.
With the renewed support of Advance Queensland, the two can plan to continue working on Queensland’s shift towards a “globally competitive life-sciences ecosystem” with the potential of improving the health and wellbeing of people in Australia and around the world.